Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradialytic Ketoacid Analogues in Hemodialysis
NCT06392516Not yet recruiting
- Sponsor
- Fatmawati Hospital
- Start
- Apr 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of Ketosteril in chronic kidney disease (CKD) (2 arms), sponsored by Fatmawati Hospital. Primary endpoints: Interleukin-6 at 12 weeks, Malnutrition Inflammation Score at 12 weeks and 3 more. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
Ketosteril
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT06392516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06392516.